(MENAFN- America News Hour) Research Nester released a report titled“Solid Phase Peptide Synthesis Market : Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global solid phase peptide synthesis market in terms of market segmentation by product, end-user, and region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global solid phase peptide synthesis market is projected to grow with a moderate CAGR during the forecast period, i.e., 2022-2030 on account of the increase in research activities associated with solid phase peptide synthesis and the development of technologically advanced solid phase peptide synthesizers. The technological growth helped researchers in realizing the potential role of peptides as therapeutic agents, and subsequently, research on the chemical synthesis of peptides advanced further, which led to the use of solid phase peptide synthesis method as the primary method for the development of peptides. As per the International Diabetes Federation, it is estimated that around 463 million people worldwide had diabetes in 2019, and by 2045, the count is projected to reach 700 million. Peptides are also deployed in the treatment of various lifestyle disorders such as diabetes and obesity in addition to their use in drug development.
Get sample for more information @
The market is segmented by product into reagents, equipment, and others. Among these segments, the equipment segment is anticipated to hold the largest share by the end of 2022 in the solid phase peptide synthesis market as a result of the higher rates of adoption of these instruments for the solid phase peptide synthesis. On the basis of end-user, the market is segmented into pharmaceutical & biotechnology industry, contract development & manufacturing organizations, academic & research institutes, and others, out of which the pharmaceutical & biotechnology industry is expected to grow significantly owing to advancement in use of peptides for therapeutic development
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the solid phase peptide synthesis market in the Asia Pacific region is projected to grow at the highest CAGR throughout the forecast period due to the growing demand for new antibody and protein-based drugs in the region. Currently, the market in North America holds the largest share. This can be attributed to the presence of well-developed healthcare infrastructure in the region, especially in the United States, along with the high research expenditure on solid state peptide synthesis technologies in the region.
Increase in Research Activities Associated with Solid Phase Peptide Synthesis to Drive Market Growth
According to the U.S. Food and Drug Administration (FDA), between 2015 and 2019, they had given authorization to a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules. This accounts for 7% of the total number of authorized drugs.
Peptides are used in diverse range of therapeutics owing to their diversity of biological functions. They are increasingly being used as potential active pharmaceutical agents for drug development. Additionally, the development of technologically advanced solid phase peptide synthesizers in recent years is also expected to boost the market growth in upcoming years. However, the issues associated with administering peptide drugs and scattered regulations for therapeutic peptides are some of the factors that are estimated to restrain market growth in the near future.
This report also provides the existing competitive scenario of some of the key players of the global solid phase peptide synthesis market which includes company profiling of AAPPTec, LLC, CEM Corporation, Bachem Holding, CSBio, Biotage, AnaSpec, Thermo Fisher Scientific, Zen-Bio Inc, New England Peptide, Inc., and GenScript Biotech Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global solid phase peptide synthesis market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get sample for more information @
About Research Nester:
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info:
AJ Daniel
Email:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Research Nester
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
MENAFN22092021004545010068ID1102841577
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.